Anaphylaxis is an acute systemic allergic reaction that can be life threatening. In adults, the most common causes of anaphylaxis are foods, drugs, and insect stings. This article reviews the definition, classification, evaluation, differential diagnosis, prognosis, complications, and management of anaphylaxis. Tailored for internists, the article focuses on anaphylactic medication allergies. It provides a guide to optimally evaluate and manage patients with antibiotic allergy using a simple, rapid risk stratification technique, graded antibiotic challenge (test dose), and/or allergist-guided drug desensitization. It also reviews other causes of anaphylaxis that internists are likely to encounter, and an approach to their management.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mcna.2019.08.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Alpha-Gal Syndrome: A Review for the General Internist.
Am J Med Sci
November 2024
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Article Synopsis
- Alpha-gal syndrome is triggered by tick bites, leading to IgE responses against alpha-gal, a carbohydrate present in mammalian meat, causing delayed allergic reactions 2 to 6 hours after eating.
- Symptoms can include skin rashes, gastrointestinal issues, and occasionally severe anaphylaxis, often starting near the previous tick bite site.
- Diagnosis involves monitoring symptom timing and prior tick bite history, with treatment focusing on immediate care during allergic reactions and long-term management requiring a strict meat-free diet.
Physicians' knowledge and practice concerning diagnosis and management of anaphylaxis: The situation in Egypt.
Afr J Emerg Med
December 2021
Department of Pediatrics, Mansoura University Children's Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Introduction: Early recognition of an anaphylaxis event is crucial for instituting lifesaving management. We sought to explore knowledge and practice towards anaphylaxis in a sample of physicians from ten Egyptian governorates.
Methods: An eighteen question-based questionnaire was developed by expert allergists to evaluate the knowledge and practice towards anaphylaxis, based on the World Allergy Organization guidelines for the assessment and management of anaphylaxis.
Hypersensitivity reactions to chemotherapy: an EAACI Position Paper.
Allergy
February 2022
Division of Allergy & Clinical Immunology, Department of Medicine, University Hospital Complex of A Coruna, A Coruna, Spain.
Chemotherapeutic drugs have been widely used in the treatment of cancer disease for about 70 years. The development of new treatments has not hindered their use, and oncologists still prescribe them routinely, alone or in combination with other antineoplastic agents. However, all chemotherapeutic agents can induce hypersensitivity reactions (HSRs), with different incidences depending on the culprit drug.
View Article and Find Full Text PDF[Allergic reactions to COVID-19 vaccines: evidence and practice-oriented approach].
Internist (Berl)
March 2021
Universitätsklinik für Hals-Nasen-Ohrenheilkunde und Kopf-Hals-Chirurgie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland.
Less than a year after the first detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines have been approved for routine use in numerous countries and have already been used in mass vaccination programs. Vaccines include the mRNA BNT162b2 and mRNA 1273. Allergic reactions and anaphylaxis account for a substantial proportion of the adverse reactions to these vaccines observed to date, but overall they are rare.
View Article and Find Full Text PDFTranexamic acid adverse reactions: a brief summary for internists and emergency doctors.
Clin Mol Allergy
September 2020
School and Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
Tranexamic acid (TXA) is a synthetic lysine analogue that is well known as antifibrinolytic agent. It can reduce blood loss in clinical use, especially in conditions where fibrinolysis or hyperfibrinolysis are involved, such as trauma or surgery. Moreover, TXA has been approved as second-line prophylactic therapy for hereditary angioedema and further data have been published about a possible use of TXA as maintenance treatment for nonhistaminergic angioedema and treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!